Loading clinical trials...
Loading clinical trials...
Reduction of PRA (Panel Reactive Antibody) in Sensitized Patients Awaiting Live-Donor Renal Transplantation
Conditions
Interventions
CMVIG
Locations
1
United States
LifeLink HealthCare Institute
Tampa, Florida, United States
Start Date
January 1, 2002
Primary Completion Date
December 1, 2010
Completion Date
April 1, 2012
Last Updated
June 29, 2015
NCT07146854
NCT04163614
NCT04580420
NCT06190717
NCT05654103
NCT03994471
Lead Sponsor
Tampa General Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions